<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01781481</url>
  </required_header>
  <id_info>
    <org_study_id>09/32E</org_study_id>
    <nct_id>NCT01781481</nct_id>
  </id_info>
  <brief_title>The Pediatric Intermed: A New Clinical Decision Making Tool</brief_title>
  <official_title>The Pediatric Intermed: A New Clinical Decision Making Tool for Proactive Evaluation of Psychosocial Stress in Children With Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Eastern Ontario</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Janssen Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Eastern Ontario</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators have recently developed a paediatric adaptation of the INTERMED tool to
      address the unique developmental and social contexts of children and youth. The Pediatric
      INTERMED adopts a life-chart methodology to structure and organize complex case material in
      time, colour-coding domains to facilitate identification of areas of high need and risk for
      each patient. The focus of the present study is to examine the characteristics and usefulness
      of the tool in identifying psychosocial stress in children/youth diagnosed with Inflammatory
      Bowel Disease (IBD), as well as identifying overall case complexity. Children and parents
      will participate in a semi-structured structured interview with a clinical nurse who will
      then rate the 34-PIM items. To examine the construct validity of each of the Pediatric
      INTERMED domains (biological, psychological, social, caregiver/family, health care system)
      participants will complete questionnaires assessing social and psychological functioning,
      parent and family stress, quality of life and adaptive functioning. Information about disease
      status, and health care utilization will be obtained from medical chart review. It is
      hypothesized that greater case complexity will be predictive of more complex disease
      course/treatment, poorer quality of life, and increased health care utilization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inflammatory Bowel Disease (Crohn's disease/ulcerative colitis) manifests itself in children
      and adolescents in up to 1/3 of those that will eventually develop these conditions. It is
      fast becoming an increasing problem with a 50% increase in Crohn's disease diagnosed in young
      children in the last decade. The patient's chronic symptoms can be both due to and result in
      increased child and family psychosocial stress. Similarly, treatments may add to psychosocial
      stress. Failure to address these psychosocial issues can lead to greater risk for poor
      treatment adherence, higher utilization of health care, and increased psychiatric
      co-morbidity. As such, improvement in health care providers' capacity to identify factors
      contributing to case complexity offers significant potential for improving outcomes.

      Assessment of biological, psychological, social and health delivery of children's chronic
      illness has not been consistently integrated into the health care system. Physical and mental
      health services are often disconnected. Identifying those who would benefit from a mental
      health referral typically rests on the primary care physician or specialist and is often
      triggered by crises. There is also variability in physician education and comfort level in
      assessing psychosocial issues and especially in children with chronic illnesses in which
      symptoms of physical disease and mental health can overlap. Oftentimes this leaves the most
      responsible physician wanting for a simple assessment tool to try and determine who might be
      at risk and benefit from mental health intervention.

      The adult INTERMED is a clinical decision-support tool that provides indicators of
      biological, psychological, social, heath care needs, as well as an overall index of case
      complexity. The tool is efficient to administer and has been successfully used by varied
      health care professionals in diverse medical settings to detect psychosocial needs,
      facilitate referral to effective services and improve health practices and outcomes. However,
      there is no comparable validated tool for use with children/youth.

      The investigators have recently developed a pediatric adaptation of the adult INTERMED to
      address the unique developmental and social contexts of children and youth. A Delphi group of
      international experts in the field of pediatric chronic illness has reviewed the instrument
      to ensure clinical relevance, utility and communication clarity. Initial pilot data has
      demonstrated the Pediatric INTERMED has very good item inter-rater reliability. The focus of
      the current study is to examine the usefulness of this tool to identify biopsychosocial needs
      in IBD children/youth. Canada has a very high IBD incidence and prevalence. Given the facts
      that children with IBD face an unpredictable disease course, complex symptoms and difficult
      management regimens that can significantly impact their lives, it is not surprising that
      patients with this chronic incurable condition are highly vulnerable to mental health
      comorbidities. The development of this new tool will have significant importance if it proves
      to be useful in this population. The current study will examine a sizeable cohort of patients
      with regards to the relations between Pediatric INTERMED domains and other measures of
      children's disease, mood, behaviour, quality of life, family stress and strengths, and health
      services utilization. Both ulcerative colitis and Crohn's disease in children and youth lend
      themselves very well to this study because of the validated measures of disease severity that
      have been developed already.

      Implementation of the novel Pediatric INTERMED n clinical practice will provide a new way to
      assist IBD Teams in screening their patients to be proactive in referral to mental health
      resources, and facilitate case management which targets patient needs. Clearly, clinicians
      are well aware that compliance, anxiety and depression will affect disease outcomes and too
      often these are only dealt with at times of crisis that has led to disease flare or reports
      that medicines are no longer effective. Use of this structured assessment tool begins to
      realize the potential of developing a truly integrated biopsychosocial approach to this
      chronic disease. The ease of use and objective nature of the tool will enhance communication
      among primary and tertiary providers and contribute to best practice approaches in the
      provision of integrated physical and mental health care. It will also assist in monitoring
      the impact of childhood chronic illness, identify factors linked to optimal health outcomes
      and inform program planning and resource allocations.

      Study Design

      Children/youth (ages of 8-17) followed in the IBD Clinic at the Children's Hospital of
      Eastern Ontario (CHEO) with confirmed diagnoses of IBD (Crohn's disease or ulcerative
      colitis) are eligible for the study. A clinical nurse will complete the Pediatric INTERMED
      for all study participants: based on information obtained from a review of the patients'
      hospital chart and a semi-structured interview conducted with the child/youth and primary
      caregivers), Following the Pediatric INTERMED interview, children/youth and parents
      participating in the project will complete a battery of self-report instruments to provide
      assessments of patients' social and psychological functioning, parent/family stresses,
      adjustment and resources. In addition, information will be obtained from the patients' charts
      about aspects of their diagnoses, treatment regimens, disease activity and complications, and
      health care utilization in the 3 months prior to their participation in the study.

      Primary Hypotheses/Objectives and Statistical Rationale

        1. Demonstrate that the Pediatric INTERMED is a reliable tool for use in IBD children (good
           inter-rater reliability and internal consistency). 40 interviews with the clinical
           research nurse will be videotaped so that a second health care professional trained in
           the use of the PIM, can also complete the PIM tool, in order to examine inter-rater
           reliability. Agreement between raters will be measured by means of intraclass
           correlations. Items within each domain will be examined to confirm that they meet
           internal consistency criteria (Cronbach's Alpha of .80).

        2. Demonstrate that the Pediatric INTERMED domains successfully identify patient needs.
           Concurrent validity of the Pediatric INTERMED will be examined by looking at the
           Spearman rank, Pearson correlations, as appropriate, between each domain score and the
           measures hypothesized to be conceptually linked to the domain. To assess aspects of the
           Psychological Domain, the patients will complete the Children's Depression Inventory,
           the Multidimensional Anxiety Scale for Children and parents will complete the Child
           Behaviour Checklist (CBCL). Measures linked to the Social Domain of the PIM, include The
           Functional Disability Inventory, which taps the child's involvement in daily activities,
           and CBCL Competence Scores (Social, School, Activities), and the IMPACT-III, an IBD
           specific quality of life measure. To examine constructs linked to the Caregiver/Family
           Domain parents will complete the Pediatric Inventory for Parents, an index of childhood
           illness-related parenting stress, the Family Inventory of Life Events and Changes and
           the Family Inventory of Resources for Management. Disease/treatment and health care data
           gathered will be used to validate the Biological and Health System Domains.

        3. Demonstrate that Pediatric INTERMED Complexity score is predictive of increased health
           care utilization. A general linear approach will be used to study the relation of the
           Pediatric INTERMED to health service utilization. Multivariate models will also be
           tested including potential covariates such as disease severity, time since diagnosis.

      Statistical Power Calculations

      The CHEO GI clinic sees 40 to 60 new patients diagnosed with IBD per year. In 2007 the clinic
      actively followed 265 children with IBD. Once diagnosed children are followed on an ongoing
      basis. The frequency of follow-up appointments varies depending on the nature and course of a
      child's disease, but the children/youth are seen at minimum three times each year. In
      general, participation rates in studies of children/youth with chronic illness are typically
      in the vicinity of 80-90% or better and this figure is consistent with the experience of the
      CHEO IBD clinic in the recruitment of patients into various knowledge generation studies. The
      PIM involves 5 domains of information inclusive of various components. To achieve
      significance with the various domains the investigators estimated that a total of 140-150
      children will need to be enrolled. This sample size is sufficient to ensure that there are a
      sufficient number of observations per variable to conduct multivariate analyses. Tabachnick
      and Fidell (2007) and others indicated that 4 is the absolute minimum number of observations
      per variable to conduct multivariate analyses. A subject size of 140-150 would be sufficient
      to provide 4 observations per variable. Further, the anticipated sample size is sufficient to
      conduct all proposed analyses. Further corrections for multiple testing will be applied on a
      per-analysis basis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pediatric INTERMED- Complexity Index</measure>
    <time_frame>Time of Study Participation (Completion of Pediatric INTERMED tool)</time_frame>
    <description>34 item screening tool which identifies biological, psychological, social, caregiver/family and health service needs that contribute to case complexity. Each item is rated on a scale from 0-3 (0= no need to act; 1= watchful waiting or preventive intervention, 2=need for action, 3=need for immediate action).
Minimum total score is 0 and Maximum score would be 102 (high complexity). Items on the Pediatric INTERMED are organized into 5 domains:
Biological Domain (6 items). Minimum score is 0 and maximum score is 18 (high biological complexity).
Psychological Domain (9 items). Minimum score is 0 and maximum score is 27 (high psychological complexity).
Social Domain (7 items). Minimum score is 0 and maximum score is 21 (high social complexity).
Family/Caregiver Domain (7 items). Minimum score is 0 and maximum score is 21 (high family/caregiver complexity).
Health Services Domain (5 items). Minimum score is 0 and maximum score is 15 (high health service complexity).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlations Between Pediatric INTERMED Domain Scores</measure>
    <time_frame>Pediatric INTERMED scores at time of study participation</time_frame>
    <description>Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED domain scores.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pediatric INTERMED Items</measure>
    <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
    <description>Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IBD Disease Severity</measure>
    <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
    <description>IBD Disease Severity Index categorizes patient's level of disease severity based on patient scores on the Pediatric Crohn's Disease Activity Index (PCDAI): (Hymans, Markowitz, Otley et al., 2005) and the Pediatric Ulcerative Colitis Activity Index (PUCAI) (Turner, Otley, Mack et al., 2007). Children's scores on either of these indices are used to categorize the severity of their disease as: inactive, mild, moderate, or severe.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time Since IBD Diagnosis</measure>
    <time_frame>Data collected through chart review at time of Pediatric INTERMED interview.</time_frame>
    <description>Time since subject's initial IBD diagnosis. Data for each subject was obtained from chart review and was coded in &quot;months since date of diagnosis&quot;, with a range from 1 - 131 months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease Course and Treatment</measure>
    <time_frame>Data collected through chart review with respect to the period since diagnosis and Day 1 (date that patient's participation in Pediatric Intermed interview)</time_frame>
    <description>Number of hospitalizations since diagnosis (total number recorded in health record), number of surgeries since diagnosis (total number recorded in health record), number of courses of Prednisone (total number recorded in health record).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IBD Treatment With Immunomodulators or Anti-TNFa Medications</measure>
    <time_frame>Information from review of participants chart from time of diagnosis until study participation (date of Pediatric INTERMED interview).</time_frame>
    <description>Use of Immunomodulators (azathioprine or methotrexate). Coded for each participant as &quot;yes&quot; (Score of 1) or &quot;no&quot; (Score of 2). Use of anti-Tumor Necrosis Factor alpha (TNFa) medications (infliximab or adalimumab). Coded for each participant as &quot;yes&quot; (Score of 1) or &quot;no&quot; (Score of 2).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional Disability Inventory</measure>
    <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
    <description>Functional Disability Inventory: (FDI); Walker &amp; Greene, 1991). The FDI assesses illness related activity limitations in children and adolescents. The measure consists of 15 items that are scored by the child and parent as (0) &quot;no trouble&quot; to &quot;(4) &quot;impossible&quot;. The minimum score is 0 and the maximum score is 60, with higher scores indicating greater functional disability. The FDI has demonstrated good psychometric properties with test-retest reliability of .92 and .85 at the 3-month follow-up. Concurrent validity was provided by correlation (r=.52, p&lt;.001) between the FDI and an objective index of disability (Walker &amp; Greene, 1991).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact-III: Quality of Life Questionnaire for Children With Inflammatory Bowel Disease.</measure>
    <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
    <description>35-item self report measure for assessing quality of life in children with IBD (Otley, Griffiths, Hale et al., 2006). Items are rated on a 5-point Likert scale, with lower scores indicating poorer health related quality of life. Scores can range from 35-175. Four factor scores can be calculated: General Well-Being, Emotional Functioning, Social Functioning, Body Image, as well as a Total Quality of Life Score (Perrin, Kuhlthau, Chughtai et al., 2008).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Child Behaviour Checklist</measure>
    <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
    <description>Child Behaviour Checklist: (CBCL: Achenbach 1991). The CBCL is used to evaluate behaviour problems and social competencies of children 6 to 18 years old. The measure is completed by parents or parent surrogates who base their ratings on the preceding 6 months. It is comprised of 120 problem items that factor into eight syndrome scales, which can be grouped into Internalizing, Externalizing and Total Problem Scales. Higher scores indicate greater level of emotional/behavioural difficulties. In the present study we utilized the following CBCL subscale scores: Internalizing, Externalizing, Social Competence, Activities Competence, Academic Competence. All scores reported are scaled to T Scores.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Children's Depression Inventory</measure>
    <time_frame>Administered at study entry</time_frame>
    <description>27 item self-report questionnaire used to measure depressive symptoms in children and youth (Kovacs 1992). Each item is rated on a 3-point Likert scale (0-2) with a minimum score of 0 and a maximum score of 54, with higher scores indicating more depressive symptoms. Raw scores were scaled to T-scores to control for age and gender differences.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Multidimensional Anxiety Scale for Children</measure>
    <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
    <description>Multidimensional Anxiety Scale for Children: (MASC; March et a., 1997). The MASC is a pediatric self-report scale that measures symptoms of anxiety. It consists of 39 items assessing physical symptoms of anxiety, harm avoidance, social anxiety and separation/panic. Each item is answered using a four point Likert scale ranging from (0) &quot;never true about me&quot; to (3) &quot;often true about me&quot;. Total scores can range from 0 to 117. The raw total score was scaled to T-Scores to control for age and sex differences.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pediatric Inventory for Parents- Difficulty Score</measure>
    <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
    <description>Pediatric Inventory for parents: (PIP; Streisand et al., 2001). The PIP is a 42-item self-report measure of parenting stress associated with caring for a medically ill child. It is the only published measure of parenting stress the specifically taps the experiences and stresses that parents face when caring for a medically ill child. The Difficulty Score - indicates parents' perception of the perceived difficulty of each stressor/item. Each item is scored on a 5 point Likert scale, with total scores ranging from 42 to 210, with higher scores indicating greater &quot;perceived difficulty&quot;.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Family Inventory of Life Events and Changes</measure>
    <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
    <description>Family Inventory of Life Events and Changes (FILE): (McCubbin &amp; Patterson, 1991). The FILE is a 71-item, yes/no instrument that assesses chronic and recent life stress in nine areas: intra-family strains, marital strains, pregnancy and childbearing strains, finance and business strains, work-family transitions and strains, illness and family care strains, losses, transition in and out, and family and legal violations. Family members indicate whether particular stressful events have occurred. The FILE has been found to have high reliability (Cronbach's alpha=.72), good test-retest reliability, internal consistency and evidence of construct validity. Scores can range from 0-71, with higher scores indicating greater family stress.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Family Inventory of Resources for Management</measure>
    <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
    <description>Family Inventory of Resources for Management (FIRM): (McCubbin &amp; Comeau 1991). The FIRM was developed to assess the family's repertoire of resources. The scale is comprised of 69 items, which are responded to using a 4-point Likert scale format (0-3). The scale has been found to have good internal reliability (r=.89, Cronbach's alpha), content and concurrent validity when used in normative sample of families with chronically ill children. The possible range for the total score is from 0-207, with higher scores indicating greater family resources for management. The Financial Well-Being subscale consists of 16 items, with potential scores ranging from 0-48, with higher scores indicating greater family financial resources.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlations Between Pediatric INTERMED Biological Domain Score/Items and Measures of Disease Severity, Disease Treatments and Functioning</measure>
    <time_frame>Pediatric INTERMED and Functioning at study participation and Disease related indices since IBD Diagnosis</time_frame>
    <description>Refer to Outcome Measure 1 and Outcome Measure 3 for information pertaining to Pediatric INTERMED domains and items. Refer to Outcome Measure 4 for information pertaining to IBD Disease Severity. Refer to Outcome Measure 5 for information pertaining to Disease Treatments. Refer to Outcome Measure 8 for information pertaining to Functioning Disability Inventory. Refer to Outcome Measure 9 for information pertaining to the IMPACT III- Quality of Life Questionnaire.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlations Between Pediatric Psychological, Social and Family Domain Scores and Measures of Emotional, Behavioural, Social and Family Functioning.</measure>
    <time_frame>Day 1 (Time of Study Participation)</time_frame>
    <description>Relations between Pediatric INTERMED Psychological, Social and Family Domain scores and other validated measures of subjects' psychosocial adjustment, including depression (Children's Depression Inventory- Outcome Measure 11), anxiety (Multidimensional Anxiety Scale for Children-Outcome Measure 12), Behavioural Adjustment (Internalizing and Externalizing Scores on the CBCL- Outcome Measure 10), Competence (Social, Activities and School Competence Scores from the CBCL- Outcome Measure 10), and family functioning (Parenting Inventory for Parents- Outcome Measure 13, Family Inventory of Life Events-Outcome Measure 14, Family Inventory of Resources for Management- Outcome Measure 15), and IBD health-related quality of life (IMPACT III: Emotional Functioning and Social Interactions scales- Outcome Measure 9).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's Total MASC Score Falls in the Clinical Range.</measure>
    <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
    <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat item when they scored in the clinical range on the Multidimensional Anxiety Scale for Children. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 12 for information pertaining to the Children's Depression Inventory. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 65 on the Multidimensional Anxiety Scale for Children were categorized as falling into the clinical range.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's Total Children's Depression Inventory (CDI) Score is in the Clinical Range.</measure>
    <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
    <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat Item when they scored in the clinical range on the Children's Depression Inventory. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 11 for information pertaining to the Children's Depression Inventory. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 65 on the Children's Depression Inventory were categorized as falling into the clinical range.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's CBCL Internalizing Score Falls in the Clinical Range.</measure>
    <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
    <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat Item when they scored in the clinical range on the Child Behavior Checklist - Internalizing Problems Scale. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 10 for information pertaining to the Child Behavior Checklist. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 63 on the Child Behavior Checklist Internalizing Scale were categorized as falling into the clinical range.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's CBCL Externalizing Score is in the Clinical Range.</measure>
    <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
    <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat Item when they scored in the clinical range on the Child Behavior Checklist - Externalizing Problems Scale. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 10 for information pertaining to the Child Behavior Checklist. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 63 on the Child Behavior Checklist Externalizing Scale were categorized as falling into the clinical range.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlations Between Pediatric Health System Domain Score/Items and Disease and Health Service Indicators</measure>
    <time_frame>Pediatric INTERMED and FIRM scores obtained at Study Entry and Disease and Health Care Indicators since IBD Diagnosis</time_frame>
    <description>Refer to Outcome Measure 1 and Outcome Measure 3 for information pertaining to Pediatric INTERMED domain scores and items. Refer to Outcome Measure 6 for information pertaining to Disease/Treatment Indicators. Refer to Outcome Measure 23 for information about the Number of Services involved in Child's Care, and to Outcome Measure 15 for information about the Family Inventory of Resources for Management.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Number of Hospital Services Involved in Child's Care.</measure>
    <time_frame>Data collected through chart review with respect to the three month period prior to Day 1 (date of patient's participation in Pediatric Intermed interview)</time_frame>
    <description>Measure of number of hospital services involved in each child's care during the three month period prior to the Pediatric INTERMED interview.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Calls to IBD Nurse</measure>
    <time_frame>Data collected through chart review with respect to the three month period prior to Day 1 (date of patient's participation in Pediatric Intermed interview)</time_frame>
    <description>Total number of calls made by patient or parent to the IBD clinic nurse during the 3-month period prior to the Pediatric Intermed Interview</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Extra Appointments With the IBD Team</measure>
    <time_frame>Data collected through chart review with respect to the three month period prior to Day 1 (date of patient's participation in Pediatric Intermed interview)</time_frame>
    <description>Number of extra appointments (unscheduled, emergency) with the IBD Team during the 3 month period prior to the Pediatric INTERMED interview.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Visits to the Hospital Emergency Department</measure>
    <time_frame>Data collected through chart review with respect to the three month period prior to Day 1 (date of patient's participation in Pediatric Intermed interview)</time_frame>
    <description>Number of times that the patient visited the hospital Emergency Department in the 3-month period prior to the Pediatric INTERMED interview.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Inpatient Hospital Admissions</measure>
    <time_frame>Data collected through chart review with respect to the three month period prior to Day 1 (date of patient's participation in Pediatric Intermed interview)</time_frame>
    <description>Total number of times that the patient was admitted to hospital during the 3-month period prior to the Pediatric INTERMED Interview.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">148</enrollment>
  <condition>Inflammatory Bowel Disease</condition>
  <arm_group>
    <arm_group_label>Children and youth with IBD</arm_group_label>
    <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All children between the ages of 8 and 17 who are followed in the CHEO GI Clinic and who
        have been diagnosed with an Inflammatory Bowel Disease (Crohn's Disease or Ulcerative
        Colitus). Once diagnosed, children are followed on an ongoing basis in the clinic for
        management of their chronic illness, with the frequency of follow-up appointments varying
        depending on the nature and course of a child's disease. Both parents of the subjects will
        be invited to participate in the study, although if only one parent is present only they
        will be included. If a child/youth is in foster placement, consent will be obtained from
        child protection officials to have the caregiver (s) most involved with the child/youth
        participate in the interview.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of IBD (Crohn's or Ulcerative Colitis)

          -  fluency in English or French

          -  between the ages of 8 and 17

          -  residing in the CHEO catchment area.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janice S Cohen, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Eastern Ontario</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital of Eastern Ontario</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Szigethy E, Craig AE, Iobst EA, Grand RJ, Keljo D, DeMaso D, Noll R. Profile of depression in adolescents with inflammatory bowel disease: implications for treatment. Inflamm Bowel Dis. 2009 Jan;15(1):69-74. doi: 10.1002/ibd.20693.</citation>
    <PMID>18831071</PMID>
  </reference>
  <reference>
    <citation>Benchimol EI, Guttmann A, Griffiths AM, Rabeneck L, Mack DR, Brill H, Howard J, Guan J, To T. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut. 2009 Nov;58(11):1490-7. doi: 10.1136/gut.2009.188383. Epub 2009 Aug 2.</citation>
    <PMID>19651626</PMID>
  </reference>
  <reference>
    <citation>Astin JA, Soeken K, Sierpina VS, Clarridge BR. Barriers to the integration of psychosocial factors in medicine: results of a national survey of physicians. J Am Board Fam Med. 2006 Nov-Dec;19(6):557-65.</citation>
    <PMID>17090789</PMID>
  </reference>
  <reference>
    <citation>Fischer CJ, Stiefel FC, De Jonge P, Guex P, Troendle A, Bulliard C, Huyse FJ, Gaillard R, Ruiz J. Case complexity and clinical outcome in diabetes mellitus. A prospective study using the INTERMED. Diabetes Metab. 2000 Sep;26(4):295-302.</citation>
    <PMID>11011222</PMID>
  </reference>
  <reference>
    <citation>Stiefel FC, Huyse FJ, SÃ¶llner W, Slaets JP, Lyons JS, Latour CH, van der Wal N, de Jonge P. Operationalizing integrated care on a clinical level: the INTERMED project. Med Clin North Am. 2006 Jul;90(4):713-58. Review.</citation>
    <PMID>16843771</PMID>
  </reference>
  <reference>
    <citation>Stiefel F, Zdrojewski C, Bel Hadj F, Boffa D, Dorogi Y, So A, Ruiz J, de Jonge P. Effects of a multifaceted psychiatric intervention targeted for the complex medically ill: a randomized controlled trial. Psychother Psychosom. 2008;77(4):247-56. doi: 10.1159/000129658. Epub 2008 Apr 28.</citation>
    <PMID>18443391</PMID>
  </reference>
  <reference>
    <citation>Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, Walters TD, Zachos M, Mamula P, Beaton DE, Steinhart AH, Griffiths AM. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007 Aug;133(2):423-32. Epub 2007 May 21.</citation>
    <PMID>17681163</PMID>
  </reference>
  <reference>
    <citation>Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, Kugathasan S, Pfefferkorn M, Tolia V, Evans J, Treem W, Wyllie R, Rothbaum R, del Rosario J, Katz A, Mezoff A, Oliva-Hemker M, Lerer T, Griffiths A; Pediatric Inflammatory Bowel Disease Collaborative Research Group. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr. 2005 Oct;41(4):416-21.</citation>
    <PMID>16205508</PMID>
  </reference>
  <reference>
    <citation>March JS, Parker JD, Sullivan K, Stallings P, Conners CK. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry. 1997 Apr;36(4):554-65.</citation>
    <PMID>9100431</PMID>
  </reference>
  <reference>
    <citation>Walker LS, Greene JW. The functional disability inventory: measuring a neglected dimension of child health status. J Pediatr Psychol. 1991 Feb;16(1):39-58.</citation>
    <PMID>1826329</PMID>
  </reference>
  <reference>
    <citation>Otley AR, Griffiths AM, Hale S, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Markowitz J, Mack D, Oliva-Hemker M, Wyllie R, Rothbaum R, Bousvaros A, Del Rosario JF, Evans J, Blanchard W, Hyams J; Pediatric IBD Collaborative Research Group. Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006 Aug;12(8):684-91.</citation>
    <PMID>16917222</PMID>
  </reference>
  <reference>
    <citation>Streisand R, Braniecki S, Tercyak KP, Kazak AE. Childhood illness-related parenting stress: the pediatric inventory for parents. J Pediatr Psychol. 2001 Apr-May;26(3):155-62.</citation>
    <PMID>11259517</PMID>
  </reference>
  <reference>
    <citation>Kovacs M. The Children's Depression, Inventory (CDI). Psychopharmacol Bull. 1985;21(4):995-8.</citation>
    <PMID>4089116</PMID>
  </reference>
  <reference>
    <citation>Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, Fedorak R, Israel D, Blanchard JF. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006 Jul;101(7):1559-68. Erratum in: Am J Gastroenterol. 2006 Aug;101(8):1945.</citation>
    <PMID>16863561</PMID>
  </reference>
  <reference>
    <citation>Mackner LM, Crandall WV, Szigethy EM. Psychosocial functioning in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006 Mar;12(3):239-44. Review.</citation>
    <PMID>16534426</PMID>
  </reference>
  <reference>
    <citation>Lyons, JS. Communimetrics. A communication theory of measurement for human services. New York: Springer, 2009.</citation>
  </reference>
  <reference>
    <citation>Han, C, Zhao N, Blank M, Gasink, C. Impact of psychiatric disorders on patients with crohn's disease: An analysis based on a healthcare claims database. Gastroenterology-Supplements 2010; 138(5), S-9.</citation>
  </reference>
  <reference>
    <citation>Kathol, R.G., Perez, R., Cohen, J.S., (2010). The Integrated Case Management Model: Assisting Complex Patients Regain Physical and Mental Health, Springer Publishing Co. N,Y,.</citation>
  </reference>
  <reference>
    <citation>Achenbach TM, Rescorla LA. Manual for ASEBA School-Age Forms &amp; Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, &amp; Families. 2001.</citation>
  </reference>
  <reference>
    <citation>McCubbin H, Patterson J. Family Inventory of Life Events and changes. In McCubbin H, Thompson A, eds. Family assessment inventories for research and practice, pp 81-100. Madison.: University of Wisconsin, 1991.</citation>
  </reference>
  <reference>
    <citation>McCubbin H, Comeau J. Family Inventory of Resources for Management. In McCubbin H, Thompson A, eds. Family assessment inventories for research and practice, pp. 81-100. Madison: University of Wisconsin, 1991.</citation>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2013</study_first_submitted>
  <study_first_submitted_qc>January 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2013</study_first_posted>
  <results_first_submitted>July 15, 2016</results_first_submitted>
  <results_first_submitted_qc>July 22, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 26, 2016</results_first_posted>
  <last_update_submitted>July 22, 2016</last_update_submitted>
  <last_update_submitted_qc>July 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Eastern Ontario</investigator_affiliation>
    <investigator_full_name>Janice S.Cohen</investigator_full_name>
    <investigator_title>Psychologist</investigator_title>
  </responsible_party>
  <keyword>Psychosocial Stress and Adjustment</keyword>
  <keyword>Pediatric Chronic Illness</keyword>
  <keyword>Decision-support tool</keyword>
  <keyword>Integrated Health Care</keyword>
  <keyword>Case Complexity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Children and Youth With IBD</title>
          <description>Children/youth (ages 8-17) with confirmed diagnoses of Inflammatory Bowel Disease (IBD).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="148"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="148"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Children and youth (ages of 8-17) followed in the IBD Clinic at the Children's Hospital of Eastern ONtario with confirmed diagnoses of IBD (Crohn's disease or ulcererative colitis).</population>
      <group_list>
        <group group_id="B1">
          <title>Children and Youth With IBD</title>
          <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="148"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.00" lower_limit="10.25" upper_limit="17.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pediatric INTERMED- Complexity Index</title>
        <description>34 item screening tool which identifies biological, psychological, social, caregiver/family and health service needs that contribute to case complexity. Each item is rated on a scale from 0-3 (0= no need to act; 1= watchful waiting or preventive intervention, 2=need for action, 3=need for immediate action).
Minimum total score is 0 and Maximum score would be 102 (high complexity). Items on the Pediatric INTERMED are organized into 5 domains:
Biological Domain (6 items). Minimum score is 0 and maximum score is 18 (high biological complexity).
Psychological Domain (9 items). Minimum score is 0 and maximum score is 27 (high psychological complexity).
Social Domain (7 items). Minimum score is 0 and maximum score is 21 (high social complexity).
Family/Caregiver Domain (7 items). Minimum score is 0 and maximum score is 21 (high family/caregiver complexity).
Health Services Domain (5 items). Minimum score is 0 and maximum score is 15 (high health service complexity).</description>
        <time_frame>Time of Study Participation (Completion of Pediatric INTERMED tool)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Pediatric INTERMED- Complexity Index</title>
          <description>34 item screening tool which identifies biological, psychological, social, caregiver/family and health service needs that contribute to case complexity. Each item is rated on a scale from 0-3 (0= no need to act; 1= watchful waiting or preventive intervention, 2=need for action, 3=need for immediate action).
Minimum total score is 0 and Maximum score would be 102 (high complexity). Items on the Pediatric INTERMED are organized into 5 domains:
Biological Domain (6 items). Minimum score is 0 and maximum score is 18 (high biological complexity).
Psychological Domain (9 items). Minimum score is 0 and maximum score is 27 (high psychological complexity).
Social Domain (7 items). Minimum score is 0 and maximum score is 21 (high social complexity).
Family/Caregiver Domain (7 items). Minimum score is 0 and maximum score is 21 (high family/caregiver complexity).
Health Services Domain (5 items). Minimum score is 0 and maximum score is 15 (high health service complexity).</description>
          <units>scores on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total Complexity Index</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24" lower_limit="8.25" upper_limit="39.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pediatric INTERMED Biological Domain Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.0" lower_limit="6" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pediatric INTERMED Psychological Domain Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pediatric INTERMED Social Domain Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" lower_limit="0" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pediatric INTERMED Caregiver/Family Domain Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" lower_limit="0" upper_limit="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pediatric INTERMED Health Service Domain Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" lower_limit="1.0" upper_limit="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Inter-rater reliability</param_type>
            <param_value>.87</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>Inter rater reliability for a subset of 40 patients whose Pediatric INTERMED was scored by two trained raters. The median inter-rater reliability coefficient was .87.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Cronbach's Alpha</param_type>
            <param_value>.91</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>Overall internal consistency of the overall Pediatric INTERMED scale (34 items).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Correlations Between Pediatric INTERMED Domain Scores</title>
        <description>Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED domain scores.</description>
        <time_frame>Pediatric INTERMED scores at time of study participation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Biological</title>
            <description>Sum of Biological Domain Item Scores</description>
          </group>
          <group group_id="O2">
            <title>Psychological</title>
            <description>Sum of Psychological Domain Item Scores</description>
          </group>
          <group group_id="O3">
            <title>Social</title>
            <description>Sum of Social Domain Item Scores</description>
          </group>
          <group group_id="O4">
            <title>Family/Caregiver</title>
            <description>Sum of Family/Caregiver Domain Item Scores</description>
          </group>
          <group group_id="O5">
            <title>Health Service</title>
            <description>Sum of Health Service Domain Item Scores</description>
          </group>
        </group_list>
        <measure>
          <title>Correlations Between Pediatric INTERMED Domain Scores</title>
          <description>Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED domain scores.</description>
          <units>Correlation Coefficient</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="148"/>
                <count group_id="O4" value="148"/>
                <count group_id="O5" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Biological</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value=".29"/>
                    <measurement group_id="O3" value=".34"/>
                    <measurement group_id="O4" value=".32"/>
                    <measurement group_id="O5" value=".19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".29"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value=".65"/>
                    <measurement group_id="O4" value=".64"/>
                    <measurement group_id="O5" value=".42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".34"/>
                    <measurement group_id="O2" value=".65"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value=".63"/>
                    <measurement group_id="O5" value=".41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caregiver/Family</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".32"/>
                    <measurement group_id="O2" value=".64"/>
                    <measurement group_id="O3" value=".63"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value=".53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Health Service</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".19"/>
                    <measurement group_id="O2" value=".42"/>
                    <measurement group_id="O3" value=".41"/>
                    <measurement group_id="O4" value=".53"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>Correlation between the biological and psychological domain scores on the Pediatric INTERMED. The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficients</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between the Biological and Social domain scores on the Pediatric INTERMED.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between the Biological and Family/Caregiver Pediatric INTERMED domain scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Biological and Health Service Pediatric INTERMED domain scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Psychology and Social Pediatric INTERMED domain scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological and Health Service Pediatric INTERMED domain scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Social and Family/Caregiver Pediatric INTERMED domain scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Social and Health Service Pediatric INTERMED domain scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Family/Caregiver and Health Service Pediatric INTERMED domain scores.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pediatric INTERMED Items</title>
        <description>Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items.</description>
        <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Score of 0</title>
            <description>Rating of 0 (No Vulnerability/Need for Action) on Pediatric INTERMED Item</description>
          </group>
          <group group_id="O2">
            <title>Score of 1</title>
            <description>Rating of 1 (Mild Vulnerability/Need for watchful waiting or preventive intervention) on Pediatric INTERMED item.</description>
          </group>
          <group group_id="O3">
            <title>Score of 2 or 3</title>
            <description>Rating of 2 (Moderate Vulnerability/Need for Action or Development of an Intervention Plan) on the Pediatric INTERMED item or Rating of 3 (Severe Vulnerability/Need for Immediate Action of Intensive Action/Plans).</description>
          </group>
        </group_list>
        <measure>
          <title>Pediatric INTERMED Items</title>
          <description>Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items.</description>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Biological: Chronicity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".7"/>
                    <measurement group_id="O2" value="1.4"/>
                    <measurement group_id="O3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Biological: Diagnostic Dilemma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".7"/>
                    <measurement group_id="O2" value="20.9"/>
                    <measurement group_id="O3" value="78.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Biological: Symptom Severity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.4"/>
                    <measurement group_id="O2" value="46.6"/>
                    <measurement group_id="O3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Biological: Diagnostic Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.8"/>
                    <measurement group_id="O2" value="20.9"/>
                    <measurement group_id="O3" value="18.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Biological: Therapeutic Complexity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7"/>
                    <measurement group_id="O2" value="6.1"/>
                    <measurement group_id="O3" value="91.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Biological: Complications and Life Threat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7"/>
                    <measurement group_id="O2" value="73.6"/>
                    <measurement group_id="O3" value="23.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological: Barriers to Coping</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.8"/>
                    <measurement group_id="O2" value="45.9"/>
                    <measurement group_id="O3" value="16.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological: Resiliency</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.9"/>
                    <measurement group_id="O2" value="43.2"/>
                    <measurement group_id="O3" value="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological: Mental Health History</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.4"/>
                    <measurement group_id="O2" value="30.4"/>
                    <measurement group_id="O3" value="18.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological: Cogntive/Intellectual Development</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.7"/>
                    <measurement group_id="O2" value="17.6"/>
                    <measurement group_id="O3" value="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological: Adverse Developmental Events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.5"/>
                    <measurement group_id="O2" value="12.8"/>
                    <measurement group_id="O3" value="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological: Resistance to Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.3"/>
                    <measurement group_id="O2" value="41.9"/>
                    <measurement group_id="O3" value="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological: Mental Health Symptoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.5"/>
                    <measurement group_id="O2" value="53.4"/>
                    <measurement group_id="O3" value="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological: Cogntive/Functinonal Impairment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.6"/>
                    <measurement group_id="O2" value="2.7"/>
                    <measurement group_id="O3" value=".7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychological: Mental Health/Cognitive Threat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.8"/>
                    <measurement group_id="O2" value="58.1"/>
                    <measurement group_id="O3" value="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social: School Functionning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.5"/>
                    <measurement group_id="O2" value="43.9"/>
                    <measurement group_id="O3" value="19.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social: Social Functioning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.5"/>
                    <measurement group_id="O2" value="24.3"/>
                    <measurement group_id="O3" value="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social: Child/Youth Supports</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.7"/>
                    <measurement group_id="O2" value="21.6"/>
                    <measurement group_id="O3" value=".7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social: School Attendance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.4"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="19.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social: Educational NEeds</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.1"/>
                    <measurement group_id="O2" value="27.7"/>
                    <measurement group_id="O3" value="18.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social: Community Participation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.5"/>
                    <measurement group_id="O2" value="28.4"/>
                    <measurement group_id="O3" value="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social System Vulnerability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.8"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Family: Family Relationships</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.8"/>
                    <measurement group_id="O2" value="33.1"/>
                    <measurement group_id="O3" value="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Family: Caregiver Health/Function</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.3"/>
                    <measurement group_id="O2" value="43.9"/>
                    <measurement group_id="O3" value="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Family: Residential Stability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.1"/>
                    <measurement group_id="O2" value="33.8"/>
                    <measurement group_id="O3" value="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Family: Caregiver/Family Support</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.5"/>
                    <measurement group_id="O2" value="25.7"/>
                    <measurement group_id="O3" value="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Family: Family Stress</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.9"/>
                    <measurement group_id="O2" value="66.9"/>
                    <measurement group_id="O3" value="18.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Family: Parental Skills</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.8"/>
                    <measurement group_id="O2" value="34.5"/>
                    <measurement group_id="O3" value="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Family/Caregiver System Vulnerability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.2"/>
                    <measurement group_id="O2" value="55.4"/>
                    <measurement group_id="O3" value="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Health System: Access to Health Care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.4"/>
                    <measurement group_id="O2" value="38.5"/>
                    <measurement group_id="O3" value="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Health System: Treatment Experience</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.4"/>
                    <measurement group_id="O2" value="43.2"/>
                    <measurement group_id="O3" value="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Health System: Organization of Care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="81.1"/>
                    <measurement group_id="O3" value="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Health System: Coordination of Care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.9"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Health System Impediments</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.5"/>
                    <measurement group_id="O2" value="61.5"/>
                    <measurement group_id="O3" value="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>IBD Disease Severity</title>
        <description>IBD Disease Severity Index categorizes patient's level of disease severity based on patient scores on the Pediatric Crohn's Disease Activity Index (PCDAI): (Hymans, Markowitz, Otley et al., 2005) and the Pediatric Ulcerative Colitis Activity Index (PUCAI) (Turner, Otley, Mack et al., 2007). Children's scores on either of these indices are used to categorize the severity of their disease as: inactive, mild, moderate, or severe.</description>
        <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Disease Severity: Remission/Inactive</title>
            <description>Disease Severity classified as in remission/inactive</description>
          </group>
          <group group_id="O2">
            <title>Disease Severity: Mild</title>
            <description>Disease Severity classified as mild</description>
          </group>
          <group group_id="O3">
            <title>Disease Severity: Moderate</title>
            <description>Disease Severity classified as moderate</description>
          </group>
          <group group_id="O4">
            <title>Disease Severity: Severe</title>
            <description>Disease Severity classified as severe</description>
          </group>
        </group_list>
        <measure>
          <title>IBD Disease Severity</title>
          <description>IBD Disease Severity Index categorizes patient's level of disease severity based on patient scores on the Pediatric Crohn's Disease Activity Index (PCDAI): (Hymans, Markowitz, Otley et al., 2005) and the Pediatric Ulcerative Colitis Activity Index (PUCAI) (Turner, Otley, Mack et al., 2007). Children's scores on either of these indices are used to categorize the severity of their disease as: inactive, mild, moderate, or severe.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="148"/>
                <count group_id="O4" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Disease Severity at Pediatric INTERMED Interview</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.8"/>
                    <measurement group_id="O2" value="25.7"/>
                    <measurement group_id="O3" value="8.1"/>
                    <measurement group_id="O4" value="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Disease Severity at Diagnosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3"/>
                    <measurement group_id="O2" value="25.7"/>
                    <measurement group_id="O3" value="32.1"/>
                    <measurement group_id="O4" value="37.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time Since IBD Diagnosis</title>
        <description>Time since subject's initial IBD diagnosis. Data for each subject was obtained from chart review and was coded in &quot;months since date of diagnosis&quot;, with a range from 1 - 131 months.</description>
        <time_frame>Data collected through chart review at time of Pediatric INTERMED interview.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Less Than 6 Months</title>
            <description>Less than 6 months since initial IBD diagnosis.</description>
          </group>
          <group group_id="O2">
            <title>6 Months-1 Year</title>
            <description>6 months to 1 year since initial IBD diagnosis.</description>
          </group>
          <group group_id="O3">
            <title>1 Year-5 Years</title>
            <description>1 - 5 years since initial IBD diagnosis.</description>
          </group>
          <group group_id="O4">
            <title>Greater Than 5 Years</title>
            <description>Greater than 5 years since initial IBD diagnosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Time Since IBD Diagnosis</title>
          <description>Time since subject's initial IBD diagnosis. Data for each subject was obtained from chart review and was coded in &quot;months since date of diagnosis&quot;, with a range from 1 - 131 months.</description>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="148"/>
                <count group_id="O4" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.5"/>
                    <measurement group_id="O2" value="34.5"/>
                    <measurement group_id="O3" value="32.4"/>
                    <measurement group_id="O4" value="17.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Disease Course and Treatment</title>
        <description>Number of hospitalizations since diagnosis (total number recorded in health record), number of surgeries since diagnosis (total number recorded in health record), number of courses of Prednisone (total number recorded in health record).</description>
        <time_frame>Data collected through chart review with respect to the period since diagnosis and Day 1 (date that patient's participation in Pediatric Intermed interview)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Disease Course and Treatment</title>
          <description>Number of hospitalizations since diagnosis (total number recorded in health record), number of surgeries since diagnosis (total number recorded in health record), number of courses of Prednisone (total number recorded in health record).</description>
          <units>number of times it occurred</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of Hospitalizations since Diagnosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of Surgeries Since Diagnosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of Courses of Prednisone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>IBD Treatment With Immunomodulators or Anti-TNFa Medications</title>
        <description>Use of Immunomodulators (azathioprine or methotrexate). Coded for each participant as &quot;yes&quot; (Score of 1) or &quot;no&quot; (Score of 2). Use of anti-Tumor Necrosis Factor alpha (TNFa) medications (infliximab or adalimumab). Coded for each participant as &quot;yes&quot; (Score of 1) or &quot;no&quot; (Score of 2).</description>
        <time_frame>Information from review of participants chart from time of diagnosis until study participation (date of Pediatric INTERMED interview).</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>IBD Treatment With Immunomodulators or Anti-TNFa Medications</title>
          <description>Use of Immunomodulators (azathioprine or methotrexate). Coded for each participant as &quot;yes&quot; (Score of 1) or &quot;no&quot; (Score of 2). Use of anti-Tumor Necrosis Factor alpha (TNFa) medications (infliximab or adalimumab). Coded for each participant as &quot;yes&quot; (Score of 1) or &quot;no&quot; (Score of 2).</description>
          <units>Percentage of participants treated</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Use of Immunomodulators</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Use of anti-TNFa Medications</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Functional Disability Inventory</title>
        <description>Functional Disability Inventory: (FDI); Walker &amp; Greene, 1991). The FDI assesses illness related activity limitations in children and adolescents. The measure consists of 15 items that are scored by the child and parent as (0) &quot;no trouble&quot; to &quot;(4) &quot;impossible&quot;. The minimum score is 0 and the maximum score is 60, with higher scores indicating greater functional disability. The FDI has demonstrated good psychometric properties with test-retest reliability of .92 and .85 at the 3-month follow-up. Concurrent validity was provided by correlation (r=.52, p&lt;.001) between the FDI and an objective index of disability (Walker &amp; Greene, 1991).</description>
        <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Functional Disability Inventory</title>
          <description>Functional Disability Inventory: (FDI); Walker &amp; Greene, 1991). The FDI assesses illness related activity limitations in children and adolescents. The measure consists of 15 items that are scored by the child and parent as (0) &quot;no trouble&quot; to &quot;(4) &quot;impossible&quot;. The minimum score is 0 and the maximum score is 60, with higher scores indicating greater functional disability. The FDI has demonstrated good psychometric properties with test-retest reliability of .92 and .85 at the 3-month follow-up. Concurrent validity was provided by correlation (r=.52, p&lt;.001) between the FDI and an objective index of disability (Walker &amp; Greene, 1991).</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>FDI - Child Report</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="0" upper_limit="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FDI- Parent Report</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Impact-III: Quality of Life Questionnaire for Children With Inflammatory Bowel Disease.</title>
        <description>35-item self report measure for assessing quality of life in children with IBD (Otley, Griffiths, Hale et al., 2006). Items are rated on a 5-point Likert scale, with lower scores indicating poorer health related quality of life. Scores can range from 35-175. Four factor scores can be calculated: General Well-Being, Emotional Functioning, Social Functioning, Body Image, as well as a Total Quality of Life Score (Perrin, Kuhlthau, Chughtai et al., 2008).</description>
        <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
        <population>The number of participants was lower due to some missing data for this indicator, due to a few participants not completing this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Impact-III: Quality of Life Questionnaire for Children With Inflammatory Bowel Disease.</title>
          <description>35-item self report measure for assessing quality of life in children with IBD (Otley, Griffiths, Hale et al., 2006). Items are rated on a 5-point Likert scale, with lower scores indicating poorer health related quality of life. Scores can range from 35-175. Four factor scores can be calculated: General Well-Being, Emotional Functioning, Social Functioning, Body Image, as well as a Total Quality of Life Score (Perrin, Kuhlthau, Chughtai et al., 2008).</description>
          <population>The number of participants was lower due to some missing data for this indicator, due to a few participants not completing this questionnaire.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="142"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Impact III: Emotional Functioning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45" lower_limit="35.75" upper_limit="54.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Impact III: Social Interactions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" lower_limit="18" upper_limit="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Impact III: General Well-Being</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57" lower_limit="43.50" upper_limit="70.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Child Behaviour Checklist</title>
        <description>Child Behaviour Checklist: (CBCL: Achenbach 1991). The CBCL is used to evaluate behaviour problems and social competencies of children 6 to 18 years old. The measure is completed by parents or parent surrogates who base their ratings on the preceding 6 months. It is comprised of 120 problem items that factor into eight syndrome scales, which can be grouped into Internalizing, Externalizing and Total Problem Scales. Higher scores indicate greater level of emotional/behavioural difficulties. In the present study we utilized the following CBCL subscale scores: Internalizing, Externalizing, Social Competence, Activities Competence, Academic Competence. All scores reported are scaled to T Scores.</description>
        <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
        <population>The number of participants was lower due to some missing data for this indicator, as a result of a few parents not having completed this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Child Behaviour Checklist</title>
          <description>Child Behaviour Checklist: (CBCL: Achenbach 1991). The CBCL is used to evaluate behaviour problems and social competencies of children 6 to 18 years old. The measure is completed by parents or parent surrogates who base their ratings on the preceding 6 months. It is comprised of 120 problem items that factor into eight syndrome scales, which can be grouped into Internalizing, Externalizing and Total Problem Scales. Higher scores indicate greater level of emotional/behavioural difficulties. In the present study we utilized the following CBCL subscale scores: Internalizing, Externalizing, Social Competence, Activities Competence, Academic Competence. All scores reported are scaled to T Scores.</description>
          <population>The number of participants was lower due to some missing data for this indicator, as a result of a few parents not having completed this questionnaire.</population>
          <units>Units on a Scale - T Scores</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CBCL Internalizing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54" lower_limit="39" upper_limit="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CBCL Externalizing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46" lower_limit="32" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CBCL Social Competence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45" lower_limit="34.50" upper_limit="55.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CBCL Activities Competence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48" lower_limit="34" upper_limit="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CBCL Academic Competence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50" lower_limit="38.5" upper_limit="51.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Children's Depression Inventory</title>
        <description>27 item self-report questionnaire used to measure depressive symptoms in children and youth (Kovacs 1992). Each item is rated on a 3-point Likert scale (0-2) with a minimum score of 0 and a maximum score of 54, with higher scores indicating more depressive symptoms. Raw scores were scaled to T-scores to control for age and gender differences.</description>
        <time_frame>Administered at study entry</time_frame>
        <population>The number of participants was lower due to some missing data for this outcome measure, as a result of a few participants not having completed this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Children's Depression Inventory</title>
          <description>27 item self-report questionnaire used to measure depressive symptoms in children and youth (Kovacs 1992). Each item is rated on a 3-point Likert scale (0-2) with a minimum score of 0 and a maximum score of 54, with higher scores indicating more depressive symptoms. Raw scores were scaled to T-scores to control for age and gender differences.</description>
          <population>The number of participants was lower due to some missing data for this outcome measure, as a result of a few participants not having completed this questionnaire.</population>
          <units>Units on a Scale - T Scores</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" lower_limit="34" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Multidimensional Anxiety Scale for Children</title>
        <description>Multidimensional Anxiety Scale for Children: (MASC; March et a., 1997). The MASC is a pediatric self-report scale that measures symptoms of anxiety. It consists of 39 items assessing physical symptoms of anxiety, harm avoidance, social anxiety and separation/panic. Each item is answered using a four point Likert scale ranging from (0) &quot;never true about me&quot; to (3) &quot;often true about me&quot;. Total scores can range from 0 to 117. The raw total score was scaled to T-Scores to control for age and sex differences.</description>
        <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
        <population>The number of participants was lower due to some missing data for this outcome measure, as a result of a few participants not having completed this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Children/Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Multidimensional Anxiety Scale for Children</title>
          <description>Multidimensional Anxiety Scale for Children: (MASC; March et a., 1997). The MASC is a pediatric self-report scale that measures symptoms of anxiety. It consists of 39 items assessing physical symptoms of anxiety, harm avoidance, social anxiety and separation/panic. Each item is answered using a four point Likert scale ranging from (0) &quot;never true about me&quot; to (3) &quot;often true about me&quot;. Total scores can range from 0 to 117. The raw total score was scaled to T-Scores to control for age and sex differences.</description>
          <population>The number of participants was lower due to some missing data for this outcome measure, as a result of a few participants not having completed this questionnaire.</population>
          <units>units on a scale- T scores</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.00" lower_limit="36.50" upper_limit="63.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pediatric Inventory for Parents- Difficulty Score</title>
        <description>Pediatric Inventory for parents: (PIP; Streisand et al., 2001). The PIP is a 42-item self-report measure of parenting stress associated with caring for a medically ill child. It is the only published measure of parenting stress the specifically taps the experiences and stresses that parents face when caring for a medically ill child. The Difficulty Score - indicates parents' perception of the perceived difficulty of each stressor/item. Each item is scored on a 5 point Likert scale, with total scores ranging from 42 to 210, with higher scores indicating greater &quot;perceived difficulty&quot;.</description>
        <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
        <population>The number of participants was lower due to some missing data for this outcome measure, as a result of a few parents not having completed this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Pediatric Inventory for Parents- Difficulty Score</title>
          <description>Pediatric Inventory for parents: (PIP; Streisand et al., 2001). The PIP is a 42-item self-report measure of parenting stress associated with caring for a medically ill child. It is the only published measure of parenting stress the specifically taps the experiences and stresses that parents face when caring for a medically ill child. The Difficulty Score - indicates parents' perception of the perceived difficulty of each stressor/item. Each item is scored on a 5 point Likert scale, with total scores ranging from 42 to 210, with higher scores indicating greater &quot;perceived difficulty&quot;.</description>
          <population>The number of participants was lower due to some missing data for this outcome measure, as a result of a few parents not having completed this questionnaire.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82" lower_limit="42.5" upper_limit="121.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Family Inventory of Life Events and Changes</title>
        <description>Family Inventory of Life Events and Changes (FILE): (McCubbin &amp; Patterson, 1991). The FILE is a 71-item, yes/no instrument that assesses chronic and recent life stress in nine areas: intra-family strains, marital strains, pregnancy and childbearing strains, finance and business strains, work-family transitions and strains, illness and family care strains, losses, transition in and out, and family and legal violations. Family members indicate whether particular stressful events have occurred. The FILE has been found to have high reliability (Cronbach's alpha=.72), good test-retest reliability, internal consistency and evidence of construct validity. Scores can range from 0-71, with higher scores indicating greater family stress.</description>
        <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
        <population>The number of participants was lower due to some missing data for this outcome measure, as a result of a few parents not having completed this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Family Inventory of Life Events and Changes</title>
          <description>Family Inventory of Life Events and Changes (FILE): (McCubbin &amp; Patterson, 1991). The FILE is a 71-item, yes/no instrument that assesses chronic and recent life stress in nine areas: intra-family strains, marital strains, pregnancy and childbearing strains, finance and business strains, work-family transitions and strains, illness and family care strains, losses, transition in and out, and family and legal violations. Family members indicate whether particular stressful events have occurred. The FILE has been found to have high reliability (Cronbach's alpha=.72), good test-retest reliability, internal consistency and evidence of construct validity. Scores can range from 0-71, with higher scores indicating greater family stress.</description>
          <population>The number of participants was lower due to some missing data for this outcome measure, as a result of a few parents not having completed this questionnaire.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="0" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Family Inventory of Resources for Management</title>
        <description>Family Inventory of Resources for Management (FIRM): (McCubbin &amp; Comeau 1991). The FIRM was developed to assess the family's repertoire of resources. The scale is comprised of 69 items, which are responded to using a 4-point Likert scale format (0-3). The scale has been found to have good internal reliability (r=.89, Cronbach's alpha), content and concurrent validity when used in normative sample of families with chronically ill children. The possible range for the total score is from 0-207, with higher scores indicating greater family resources for management. The Financial Well-Being subscale consists of 16 items, with potential scores ranging from 0-48, with higher scores indicating greater family financial resources.</description>
        <time_frame>Day 1 (Date of patient's participation in the Pediatric Intermed interview).</time_frame>
        <population>The number of participants was lower due to some missing data for this outcome measure, as a result of a few parents not having completed this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Family Inventory of Resources for Management</title>
          <description>Family Inventory of Resources for Management (FIRM): (McCubbin &amp; Comeau 1991). The FIRM was developed to assess the family's repertoire of resources. The scale is comprised of 69 items, which are responded to using a 4-point Likert scale format (0-3). The scale has been found to have good internal reliability (r=.89, Cronbach's alpha), content and concurrent validity when used in normative sample of families with chronically ill children. The possible range for the total score is from 0-207, with higher scores indicating greater family resources for management. The Financial Well-Being subscale consists of 16 items, with potential scores ranging from 0-48, with higher scores indicating greater family financial resources.</description>
          <population>The number of participants was lower due to some missing data for this outcome measure, as a result of a few parents not having completed this questionnaire.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Firm: Total Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127" lower_limit="99" upper_limit="155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FIRM: Financial Well-being Scale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36" lower_limit="24.50" upper_limit="37.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Correlations Between Pediatric INTERMED Biological Domain Score/Items and Measures of Disease Severity, Disease Treatments and Functioning</title>
        <description>Refer to Outcome Measure 1 and Outcome Measure 3 for information pertaining to Pediatric INTERMED domains and items. Refer to Outcome Measure 4 for information pertaining to IBD Disease Severity. Refer to Outcome Measure 5 for information pertaining to Disease Treatments. Refer to Outcome Measure 8 for information pertaining to Functioning Disability Inventory. Refer to Outcome Measure 9 for information pertaining to the IMPACT III- Quality of Life Questionnaire.</description>
        <time_frame>Pediatric INTERMED and Functioning at study participation and Disease related indices since IBD Diagnosis</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pediatric INTERMED Biological Domain Score</title>
            <description>Sum of all Pediatric INTERMED Biological domain item scores.</description>
          </group>
          <group group_id="O2">
            <title>Historical Biological Item: Chronicity</title>
            <description>This item taps the extent and chronicity of child's physical health issues.</description>
          </group>
          <group group_id="O3">
            <title>Historical Biological Item: Diagnostic Dilemma</title>
            <description>This item taps whether or not the child/youth has been seeking care for physical complaints across a substantial portion of their life and whether or not these complaints have been resolved.</description>
          </group>
          <group group_id="O4">
            <title>Current Biological Item: Symptom Severity</title>
            <description>This item taps the severity/acuity of the child's current physical symptoms, and the extent to which they impact on current functioning.</description>
          </group>
          <group group_id="O5">
            <title>Current Biological Item: Diagnostic/Therapeutic Challenge</title>
            <description>This item refers to the presence of physical symptoms that result in current diagnostic questions or therapeutic challenges.</description>
          </group>
          <group group_id="O6">
            <title>Current Biological Item: Therapeutic Complexity</title>
            <description>This item taps whether a child's treatment for their disease is clear, unequivocal or non-invasive or requires more complex regimens which are perceived by the patient/caregivers to be time-consuming, demanding or aversive.</description>
          </group>
          <group group_id="O7">
            <title>Vulnerability Biological Item: Complications and Life Threat</title>
            <description>This item taps the excepted functional impact of the present medical condition over the next 3-6 months based on the child' condition and experience with similar cases.</description>
          </group>
        </group_list>
        <measure>
          <title>Correlations Between Pediatric INTERMED Biological Domain Score/Items and Measures of Disease Severity, Disease Treatments and Functioning</title>
          <description>Refer to Outcome Measure 1 and Outcome Measure 3 for information pertaining to Pediatric INTERMED domains and items. Refer to Outcome Measure 4 for information pertaining to IBD Disease Severity. Refer to Outcome Measure 5 for information pertaining to Disease Treatments. Refer to Outcome Measure 8 for information pertaining to Functioning Disability Inventory. Refer to Outcome Measure 9 for information pertaining to the IMPACT III- Quality of Life Questionnaire.</description>
          <units>Correlation Coefficients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="148"/>
                <count group_id="O4" value="148"/>
                <count group_id="O5" value="148"/>
                <count group_id="O6" value="148"/>
                <count group_id="O7" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Disease Severity at Diagnosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.06"/>
                    <measurement group_id="O2" value=".06"/>
                    <measurement group_id="O3" value="-.12"/>
                    <measurement group_id="O4" value=".09"/>
                    <measurement group_id="O5" value="-.15"/>
                    <measurement group_id="O6" value=".04"/>
                    <measurement group_id="O7" value="-.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Disease Severity at Study Enrolment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".36"/>
                    <measurement group_id="O2" value=".01"/>
                    <measurement group_id="O3" value="-.08"/>
                    <measurement group_id="O4" value=".53"/>
                    <measurement group_id="O5" value=".20"/>
                    <measurement group_id="O6" value=".17"/>
                    <measurement group_id="O7" value=".18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Functional Disability Index- Child Rating</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".50"/>
                    <measurement group_id="O2" value=".16"/>
                    <measurement group_id="O3" value=".00"/>
                    <measurement group_id="O4" value=".56"/>
                    <measurement group_id="O5" value=".20"/>
                    <measurement group_id="O6" value=".03"/>
                    <measurement group_id="O7" value=".23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Functional Disability Index - Parent Rating</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".52"/>
                    <measurement group_id="O2" value=".27"/>
                    <measurement group_id="O3" value="-.10"/>
                    <measurement group_id="O4" value=".51"/>
                    <measurement group_id="O5" value=".14"/>
                    <measurement group_id="O6" value=".09"/>
                    <measurement group_id="O7" value=".27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Impact III: General Well-Being Scale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.45"/>
                    <measurement group_id="O2" value="-.05"/>
                    <measurement group_id="O3" value=".03"/>
                    <measurement group_id="O4" value="-.65"/>
                    <measurement group_id="O5" value="-.24"/>
                    <measurement group_id="O6" value="-.01"/>
                    <measurement group_id="O7" value="-.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of Surgeries since Diagnosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".00"/>
                    <measurement group_id="O2" value=".10"/>
                    <measurement group_id="O3" value=".15"/>
                    <measurement group_id="O4" value=".02"/>
                    <measurement group_id="O5" value=".09"/>
                    <measurement group_id="O6" value="-.14"/>
                    <measurement group_id="O7" value=".13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of Courses of Prednisone since Diagnosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".10"/>
                    <measurement group_id="O2" value=".08"/>
                    <measurement group_id="O3" value=".06"/>
                    <measurement group_id="O4" value="-.01"/>
                    <measurement group_id="O5" value="-.10"/>
                    <measurement group_id="O6" value=".18"/>
                    <measurement group_id="O7" value="-.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Use of Chemical Immunomodulators since Diagnosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.11"/>
                    <measurement group_id="O2" value="-.18"/>
                    <measurement group_id="O3" value="-.11"/>
                    <measurement group_id="O4" value=".16"/>
                    <measurement group_id="O5" value=".07"/>
                    <measurement group_id="O6" value="-.42"/>
                    <measurement group_id="O7" value="-.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Use of Biological Immunodulators Since Diagnosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.09"/>
                    <measurement group_id="O2" value=".13"/>
                    <measurement group_id="O3" value="-.04"/>
                    <measurement group_id="O4" value="-.09"/>
                    <measurement group_id="O5" value=".12"/>
                    <measurement group_id="O6" value="-.32"/>
                    <measurement group_id="O7" value="-.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Biological Domain Score and IBD Disease Severity at Diagnosis</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Biological Domain Score and IBD Disease Severity (at time of Study Participation).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Biological Domain Score and Functional Disability Index (child rating).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt; .05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Biological Domain Score and Functional Disability Index (parent rating).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Biological Domain Score and Impact Quality of Life: General Well Being scale.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Biological Domain Score and Number of Surgeries.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Biological Domain Score and Number of Courses of Prednisone.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Biological Domain Score and Use of Immunomodulators.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Biological Domain Score and Use of ant-TNFa medications.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Chronicity Item (Historical Biological) and Disease Severity at Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Chronicity Item (Historical Biological) and Disease Severity at time of study participation (Pediatric INTERMED interview).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Chronicity Item (Historical Biological) and Functional Disability Index (Child Report)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Chronicity Item (Historical Biological) and Functional Disability Index (Parent)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Chronicity Item (Historical Biological) and Impact Quality of Life: General Well-Being.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Chronicity Item (Historical Biological) and Number of Surgeries.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Chronicity Item (Historical Biological) and Number of Courses of Prednisone.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Chronicity Item (Historical Biological) and Use of Immunomodulators (azathioprine or methotrexate)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt; 0.05.</p_value_desc>
            <method>Spearman Correlation Coefficent</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Chronicity Item (Historical Biological) and use of anti-TNFa medications.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Symptom Severity&quot; Item (Current/Biological) and Disease Severity at Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Symptom Severity&quot; Item (Current Biological) and IBD Disease Severity at time of study participation.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Symptom Severity&quot; Item (Current Biological) and Functional Disability Index (child rating).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Symptom Severity&quot; Item (Current Biological) and Functional Disability Index (Parent Rating)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Symptom Severity&quot; Item (Current Biological) and Impact Quality of Life: General Well-Being Scale</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Symptom Severity&quot; Item (Current/Biological) and Number of Surgeries</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Symptom Severity&quot; Item (Current/Biological) and Number of Courses of Prednisone.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Symptom Severity&quot; Item (Current/Biological) and Use of Immunomodulators.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Symptom Severity&quot; Item (Current/Biological) and Use of anti-TNFa Medications.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlations between Pediatric INTERMED &quot;Diagnostic Dilemma&quot; Item (Historical Biological) and Functional Disability Index (Parent) and each of the following variables: Disease Severity at Diagnosis, Disease Severity at Interview, Functional Disability Index - Child, Functional Disability Index- Parent, Impact Quality of Life: General Well Being, Number of Surgeries, Number of Courses of Prednisone, Use of Immunomodulators, Use of Anti-TNFa Medications.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05. The P-Value indicated above was found for all the correlations which were examined.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Diagnostic/Therapeutic Challenge&quot; Item (Current Biological) and IBD Disease Severity at Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Diagnostic/Therapeutic Challenge&quot; Item (Current Biological) and IBD Disease Severity at time of study participation.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Diagnostic/Therapeutic Challenge&quot; Item (Current Biological) and Functional Disability Index (Child Rating)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Diagnostic/Therapeutic Challenge&quot; Item (Current Biological) and Functional Disability Index (parent rating).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Diagnostic/Therapeutic Challenge&quot; Item (Current Biological) and Impact Quality of LIfe: General Well-Being Scale</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Diagnostic/Therapeutic Challenge&quot; Item (Current Biological) and Number of Surgeries.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Diagnostic/Therapeutic Challenge&quot; Item (Current Biological) and Number of Courses of Prednisone.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Diagnostic/Therapeutic Challenge&quot; Item (Current Biological) and Use of Immunomodulators. .</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Diagnostic/Therapeutic Challenge&quot; Item (Current Biological) and Use of anti-TNFa Medications</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Therapeutic Complexity&quot; Item (Current Biological) and Disease Severity at Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Therapeutic Complexity&quot; Item (Current Biological) and Disease Severity at time of study participation (Pediatric INTERMED interview).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Therapeutic Complexity&quot; Item (Current Biological) and Functional Disability Index (Child Rating).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Therapeutic Complexity&quot; Item (Current Biological) and Functional Disability Index (Parent Rating)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Therapeutic Complexity&quot; Item (Current Biological) and Impact Quality of Life: General Well-Being</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Therapeutic Complexity&quot; Item (Current Biological) and Number of Surgeries.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Therapeutic Complexity&quot; Item (Current Biological) and Number of Courses of Prednisone since diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Therapeutic Complexity&quot; Item (Current Biological) and Use of Immunomodulators (azathioprine or methotrexate).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significiance is p&lt;0.01.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Therapeutic Complexity&quot; Item (Current Biological) and Use of ant-TNFa Medications (infliximab or adalimumab).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The Threshold for significance is p&lt;0.05)</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Complications and Life Threat&quot; Item (Vulnerability Biological) and Disease Severity at diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Complications and Life Threat&quot; Item (Vulnerability Biological) and Disease Severity at study participation.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Complications and Life Threat&quot; Item (Vulnerability Biological) and Functional Disability Index (Child Rating).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Complications and Life Threat&quot; Item (Vulnerability Biological) and Functional Disability Index (parent rating).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.01.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Complications and Life Threat&quot; Item (Vulnerability Biological) and Impact Quality of Life: General Well Being Scale.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Complications and Life Threat&quot; Item (Vulnerability Biological) and Number of Surgeries.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Complications and Life Threat&quot; Item (Vulnerability Biological) and Number of Courses of Prednisone.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Complications and Life Threat&quot; Item (Vulnerability Biological) and Use of Immunomodulators (azathioprine or methotrexate).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O7</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Complications and Life Threat&quot; Item (Vulnerability Biological) and Use of anti-TNFa Medications.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Correlations Between Pediatric Psychological, Social and Family Domain Scores and Measures of Emotional, Behavioural, Social and Family Functioning.</title>
        <description>Relations between Pediatric INTERMED Psychological, Social and Family Domain scores and other validated measures of subjects' psychosocial adjustment, including depression (Children's Depression Inventory- Outcome Measure 11), anxiety (Multidimensional Anxiety Scale for Children-Outcome Measure 12), Behavioural Adjustment (Internalizing and Externalizing Scores on the CBCL- Outcome Measure 10), Competence (Social, Activities and School Competence Scores from the CBCL- Outcome Measure 10), and family functioning (Parenting Inventory for Parents- Outcome Measure 13, Family Inventory of Life Events-Outcome Measure 14, Family Inventory of Resources for Management- Outcome Measure 15), and IBD health-related quality of life (IMPACT III: Emotional Functioning and Social Interactions scales- Outcome Measure 9).</description>
        <time_frame>Day 1 (Time of Study Participation)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pediatric INTERMED Psychological Domain Score</title>
            <description>Sum of Pediatric INTERMED Psychological Domain item scores</description>
          </group>
          <group group_id="O2">
            <title>Pediatric INTERMED Social Domain Score</title>
            <description>Sum of Pediatric INTERMED Social Domain items scores</description>
          </group>
          <group group_id="O3">
            <title>Pediatric INTERMED Caregiver/Family Domain Score</title>
            <description>Sum of Pediatric INTERMED Caregiver/Family Domain item scores</description>
          </group>
        </group_list>
        <measure>
          <title>Correlations Between Pediatric Psychological, Social and Family Domain Scores and Measures of Emotional, Behavioural, Social and Family Functioning.</title>
          <description>Relations between Pediatric INTERMED Psychological, Social and Family Domain scores and other validated measures of subjects' psychosocial adjustment, including depression (Children's Depression Inventory- Outcome Measure 11), anxiety (Multidimensional Anxiety Scale for Children-Outcome Measure 12), Behavioural Adjustment (Internalizing and Externalizing Scores on the CBCL- Outcome Measure 10), Competence (Social, Activities and School Competence Scores from the CBCL- Outcome Measure 10), and family functioning (Parenting Inventory for Parents- Outcome Measure 13, Family Inventory of Life Events-Outcome Measure 14, Family Inventory of Resources for Management- Outcome Measure 15), and IBD health-related quality of life (IMPACT III: Emotional Functioning and Social Interactions scales- Outcome Measure 9).</description>
          <units>Pearson Correlation Coefficient</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
                <count group_id="O2" value="133"/>
                <count group_id="O3" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CBCL Internalizing Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".56"/>
                    <measurement group_id="O2" value=".46"/>
                    <measurement group_id="O3" value=".46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CBCL Externalizing Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".52"/>
                    <measurement group_id="O2" value=".42"/>
                    <measurement group_id="O3" value=".38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Children's Depression Inventory</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".41"/>
                    <measurement group_id="O2" value=".46"/>
                    <measurement group_id="O3" value=".38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Multidimensional Anxiety Scale for Children</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".24"/>
                    <measurement group_id="O2" value=".19"/>
                    <measurement group_id="O3" value=".14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Impact III: Emotional Functioning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.35"/>
                    <measurement group_id="O2" value="-.30"/>
                    <measurement group_id="O3" value="-.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CBCL Social Competence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.32"/>
                    <measurement group_id="O2" value="-.38"/>
                    <measurement group_id="O3" value="-.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CBCL Activities Competence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.18"/>
                    <measurement group_id="O2" value="-.23"/>
                    <measurement group_id="O3" value="-.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CBCL Academic Competence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.50"/>
                    <measurement group_id="O2" value="-.59"/>
                    <measurement group_id="O3" value="-.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Impact III: Social Interactions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".40"/>
                    <measurement group_id="O2" value="-.38"/>
                    <measurement group_id="O3" value="-.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PIP Difficulty Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".22"/>
                    <measurement group_id="O2" value=".41"/>
                    <measurement group_id="O3" value=".39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Family Inventory of Life Events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".31"/>
                    <measurement group_id="O2" value=".36"/>
                    <measurement group_id="O3" value=".41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Family Inventory of Resources for Management</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.26"/>
                    <measurement group_id="O2" value="-.28"/>
                    <measurement group_id="O3" value="-.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Internalizing Problems (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Externalizing Problems (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Children's Depression Inventory: Total Score</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Multidimensional Anxiety Scale for Children: Total Score.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Impact Quality of Life: Emotional Scale</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Social Competence Scale (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Activities Competence Scale (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Academic Competence Scale (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Impact Quality of Life: Social Scale</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Pediatric Inventory for Parents: Difficulty Score (parenting stress).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Family Inventory of Life Events (family stress measure).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Family Inventory of Resources for Management (family resources measure).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Internalizing Problems (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Externalizing Problems (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Children's Depression Inventory: Total Score</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Multidimensional Anxiety Scale for Children: Total Score.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Impact Quality of Life: Emotional Scale</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Social Competence Scale (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Activities Competence Scale (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Academic Competence Scale (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Impact Quality of Life: Social Scale</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Pediatric Inventory for Parents: Difficulty Score (parenting stress).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Family Inventory of Life Events (family stress measure).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Social Domain Score (social needs) and Family Inventory of Resources for Management (family resources measure).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Caregiver/Family Domain Score (caregiver/family needs) and Internalizing Problems (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Caregiver/Family Domain Score (caregiver/family needs) and Externalizing Problems (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Caregiver/Family Domain Score (caregiver/family needs) and Children's Depression Inventory: Total Score</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Caregiver/Family Domain Score (caregiver/family needs) and Multidimensional Anxiety Scale for Children: Total Score.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Impact Quality of Life: Emotional Scale</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Caregiver/Family Domain Score (caregiver/family needs) and Social Competence Scale (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Caregiver/Family Domain Score (caregiver/family needs) and Activities Competence Scale (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Caregiver/Family Domain Score (caregiver/family needs) and Academic Competence Scale (Child Behaviour Checklist).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Caregiver/Family Domain Score (caregiver/family needs) and Impact Quality of Life: Social Scale</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Caregiver/Family Domain Score (caregiver/family needs) and Pediatric Inventory for Parents: Difficulty Score (parenting stress).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Psychological Domain Score (psychological needs) and Family Inventory of Life Events (family stress measure).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Caregiver/Family Domain Score (caregiver/family needs) and Family Inventory of Resources for Management (family resources measure).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's Total MASC Score Falls in the Clinical Range.</title>
        <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat item when they scored in the clinical range on the Multidimensional Anxiety Scale for Children. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 12 for information pertaining to the Children's Depression Inventory. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 65 on the Multidimensional Anxiety Scale for Children were categorized as falling into the clinical range.</description>
        <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
        <population>The number of participants was lower due to some missing data for the MASC measure, due to fewer participants completing this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects With MASC Scores in the Clinical Range.</title>
            <description>Children whose scores on the Multidimensional Anxiety Scale for Children fell within the clinical range.</description>
          </group>
          <group group_id="O2">
            <title>Subjects With MASC Scores in the Non-clinical Range</title>
            <description>Children whose scores on the Multidimensional Anxiety Scale for Children fell below the clinical range.</description>
          </group>
        </group_list>
        <measure>
          <title>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's Total MASC Score Falls in the Clinical Range.</title>
          <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat item when they scored in the clinical range on the Multidimensional Anxiety Scale for Children. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 12 for information pertaining to the Children's Depression Inventory. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 65 on the Multidimensional Anxiety Scale for Children were categorized as falling into the clinical range.</description>
          <population>The number of participants was lower due to some missing data for the MASC measure, due to fewer participants completing this questionnaire.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="145"/>
                <count group_id="O2" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mental Health/Cognitive Vulnerability Need</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Mental Health/Cognitive Vulnerability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>8.33</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.02</ci_lower_limit>
            <ci_upper_limit>34.47</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's Total Children's Depression Inventory (CDI) Score is in the Clinical Range.</title>
        <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat Item when they scored in the clinical range on the Children's Depression Inventory. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 11 for information pertaining to the Children's Depression Inventory. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 65 on the Children's Depression Inventory were categorized as falling into the clinical range.</description>
        <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
        <population>The number of participants was lower due to some missing data for the CDI measure, due to fewer participants completing this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects With CDI Scores in the Clinical Range.</title>
            <description>Children whose scores on the Children's Depression Inventory fell within the clinical range.</description>
          </group>
          <group group_id="O2">
            <title>Subjects With CDI Scores in the Non-clinical Range</title>
            <description>Children whose scores on the Children's Depression Inventory fell below the clinical range.</description>
          </group>
        </group_list>
        <measure>
          <title>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's Total Children's Depression Inventory (CDI) Score is in the Clinical Range.</title>
          <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat Item when they scored in the clinical range on the Children's Depression Inventory. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 11 for information pertaining to the Children's Depression Inventory. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 65 on the Children's Depression Inventory were categorized as falling into the clinical range.</description>
          <population>The number of participants was lower due to some missing data for the CDI measure, due to fewer participants completing this questionnaire.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="143"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mental Health/Cognitive Vulnerability Need</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Mental Health/Cognitive Vulnerability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>8.52</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.70</ci_lower_limit>
            <ci_upper_limit>43.02</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's CBCL Internalizing Score Falls in the Clinical Range.</title>
        <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat Item when they scored in the clinical range on the Child Behavior Checklist - Internalizing Problems Scale. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 10 for information pertaining to the Child Behavior Checklist. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 63 on the Child Behavior Checklist Internalizing Scale were categorized as falling into the clinical range.</description>
        <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
        <population>The number of participants was lower due to some missing data for the CBCL measure, due to fewer participants completing this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>CBCL Internalizing Score in the Clinical Range.</title>
            <description>Children whose scores on the CBCL Internalizing Scale fell within the clinical range.</description>
          </group>
          <group group_id="O2">
            <title>CBCL Internalizing Score in the Non-clinical Range</title>
            <description>Children's whose scores on the CBCL Internalizing Scale fell below the clinical range.</description>
          </group>
        </group_list>
        <measure>
          <title>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's CBCL Internalizing Score Falls in the Clinical Range.</title>
          <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat Item when they scored in the clinical range on the Child Behavior Checklist - Internalizing Problems Scale. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 10 for information pertaining to the Child Behavior Checklist. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 63 on the Child Behavior Checklist Internalizing Scale were categorized as falling into the clinical range.</description>
          <population>The number of participants was lower due to some missing data for the CBCL measure, due to fewer participants completing this questionnaire.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
                <count group_id="O2" value="135"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mental Health/Cognitive Vulnerability Need</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Mental Health/Cognitive Vulnerability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>7.27</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.17</ci_lower_limit>
            <ci_upper_limit>24.36</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's CBCL Externalizing Score is in the Clinical Range.</title>
        <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat Item when they scored in the clinical range on the Child Behavior Checklist - Externalizing Problems Scale. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 10 for information pertaining to the Child Behavior Checklist. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 63 on the Child Behavior Checklist Externalizing Scale were categorized as falling into the clinical range.</description>
        <time_frame>Day 1 (At time of Pediatric Intermed Interview)</time_frame>
        <population>The number of participants was lower due to some missing data for the CBCL measure, due to fewer participants completing this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>CBCL Externalizing Score in the Clinical Range.</title>
            <description>Children whose scores on the CBCL Externalizing scale fell within the clinical range.</description>
          </group>
          <group group_id="O2">
            <title>CBCL Externalizing Score in the Non-clinical Range</title>
            <description>Children whose scores on the CBCL Externalizing Scale fell below the clinical range.</description>
          </group>
        </group_list>
        <measure>
          <title>Likelihood of Being Identified as Having a Mental Health Need on the Pediatric INTERMED Mental/Cognitive Threat Item When Subject's CBCL Externalizing Score is in the Clinical Range.</title>
          <description>This outcome examined the increase in odds of a participant being identified as being rated as having a mental health need on the Pediatric INTERMED Mental Health/Cognitive Threat Item when they scored in the clinical range on the Child Behavior Checklist - Externalizing Problems Scale. Refer to Outcome Measure 1 for information pertaining to Pediatric INTERMED items. Refer to Outcome Measure 10 for information pertaining to the Child Behavior Checklist. Subjects were categorized into two groups based on their scores on Pediatric INTERMED Mental Health/Cognitive Threat ITEM: low psychological need (rating of 0 or 1) and high psychological need (rating of 2 or 3). Children with T scores above 63 on the Child Behavior Checklist Externalizing Scale were categorized as falling into the clinical range.</description>
          <population>The number of participants was lower due to some missing data for the CBCL measure, due to fewer participants completing this questionnaire.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
                <count group_id="O2" value="135"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mental Health/Cognitive Vulnerability Need</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Mental Health/Cognitive Vulnerability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>24.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>5.00</ci_lower_limit>
            <ci_upper_limit>122.84</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Correlations Between Pediatric Health System Domain Score/Items and Disease and Health Service Indicators</title>
        <description>Refer to Outcome Measure 1 and Outcome Measure 3 for information pertaining to Pediatric INTERMED domain scores and items. Refer to Outcome Measure 6 for information pertaining to Disease/Treatment Indicators. Refer to Outcome Measure 23 for information about the Number of Services involved in Child's Care, and to Outcome Measure 15 for information about the Family Inventory of Resources for Management.</description>
        <time_frame>Pediatric INTERMED and FIRM scores obtained at Study Entry and Disease and Health Care Indicators since IBD Diagnosis</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pediatric Intermed: Health System Domain Score</title>
            <description>Sum of Pediatric INTERMED health system item scores.</description>
          </group>
          <group group_id="O2">
            <title>Historical Health System Item: Access to Health Care</title>
            <description>This item refers to anything in the past that served as an obstacle, hindering the patient's access to healthcare.</description>
          </group>
          <group group_id="O3">
            <title>Historical Health System Item: Treatment Experience</title>
            <description>This item describes the degree to which the child and family's prior health care experiences have been positive in terms of good outcomes and relationships with health care providers.</description>
          </group>
          <group group_id="O4">
            <title>Current Health System Item: Organization of Care</title>
            <description>This item describes the nature and organization of the health care services that the child is current receiving.</description>
          </group>
          <group group_id="O5">
            <title>Current Health System Item: Coordination of Care</title>
            <description>This item describes the extent to which the different health care providers working with the child are in contact with each other.</description>
          </group>
          <group group_id="O6">
            <title>Vulnerability Health System Item: Health System Impediments</title>
            <description>This item anticipates the problems that the child/youth may encounter in the next 3-6 months in receiving the services he/she requires.</description>
          </group>
        </group_list>
        <measure>
          <title>Correlations Between Pediatric Health System Domain Score/Items and Disease and Health Service Indicators</title>
          <description>Refer to Outcome Measure 1 and Outcome Measure 3 for information pertaining to Pediatric INTERMED domain scores and items. Refer to Outcome Measure 6 for information pertaining to Disease/Treatment Indicators. Refer to Outcome Measure 23 for information about the Number of Services involved in Child's Care, and to Outcome Measure 15 for information about the Family Inventory of Resources for Management.</description>
          <units>Correlation Coefficients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="148"/>
                <count group_id="O4" value="148"/>
                <count group_id="O5" value="148"/>
                <count group_id="O6" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of Services involved in Child's Care</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".26"/>
                    <measurement group_id="O2" value=".08"/>
                    <measurement group_id="O3" value=".25"/>
                    <measurement group_id="O4" value=".37"/>
                    <measurement group_id="O5" value=".20"/>
                    <measurement group_id="O6" value=".15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of Hospitalizations since Diagnosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".34"/>
                    <measurement group_id="O2" value=".36"/>
                    <measurement group_id="O3" value=".14"/>
                    <measurement group_id="O4" value=".11"/>
                    <measurement group_id="O5" value=".09"/>
                    <measurement group_id="O6" value=".23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Numbers of Surgeries since Hospitalization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".22"/>
                    <measurement group_id="O2" value=".25"/>
                    <measurement group_id="O3" value=".10"/>
                    <measurement group_id="O4" value=".08"/>
                    <measurement group_id="O5" value=".13"/>
                    <measurement group_id="O6" value=".11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FIRM: Financial Well Being Scale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.32"/>
                    <measurement group_id="O2" value="-.34"/>
                    <measurement group_id="O3" value="-.13"/>
                    <measurement group_id="O4" value="-.03"/>
                    <measurement group_id="O5" value="-.15"/>
                    <measurement group_id="O6" value="-.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Health System Domain Score (health system needs/complexity) and Number of Hospital Services involved in the child's care.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Health System Domain Score (health system needs/complexity) and Number of Inpatient Hospitalizations since IBD diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Health System Domain Score (health system needs/complexity) and Number of Surgeries since IBD diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED Health System Domain Score (health system needs/complexity) and Family Financial Well Being</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Pearson Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Access to Health Care&quot; Item (historical/health system) and Number of Hospital Services Involved in the Child's Care.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Access to Health Care&quot; Item (historical/health system) and Number of Hospitalizations since Child's IBD Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Access to Health Care&quot; Item (historical/health system) and Number of Surgeries since Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Access to Health Care&quot; Item (historical/health system) and Family Financial Well-Being.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Treatment Experience&quot; Item (historical/health system) and Number of Hospital Services Involved in the Child's Care.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Treatment Experience&quot; Item (historical/health system) and Number of Hospitalizations since Child's IBD Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Treatment Experience&quot; Item (historical/health system) and Number of Surgeries since child's diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Treatment Experience&quot; Item (historical/health system) and Family Financial Well-Being.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Organization of Care&quot; Item (current/health system) and Number of Hospital Services Involved in the Child's Care.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Organization of Care&quot; Item (current/health system) and Number of Hospitalizations since IBD Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Organization of Care&quot; Item (current/health system) and Number of Surgeries since Child's IBD Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Organization of Care&quot; Item (current/health system) and Family Financial Well-Being.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Coordination of Care&quot; Item (current/health system) and Number of Hospital Services Involved in the Child's Care.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Coordination of Care&quot; Item (current/health system) and Number of Hospitalizations since Child's IBD Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Coordination of Care&quot; Item (current/health system) and Number of Surgeries Child's IBD Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Coordination of Care&quot; Item (current/health system) and Family Financial Well Being.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Health System Impediments&quot; Item (vulnerability/health system) and Number of Hospital Services Involved in the Child's Care.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Health System Impediments&quot; Item (vulnerability/health system) and Number of Hospitalizations since Child's IBD Diagnosis. Services Involved in the Child's Care.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Health System Impediments&quot; Item (vulnerability/health system) and Number of Surgeries since Child's IBD Diagnosis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
            </group_id_list>
            <groups_desc>Correlation between Pediatric INTERMED &quot;Health System Impediments&quot; Item (vulnerability/health system) and Family Financial Well-Being.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>The threshold for significance is p&lt;0.05.</p_value_desc>
            <method>Spearman Correlation Coefficient</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Number of Hospital Services Involved in Child's Care.</title>
        <description>Measure of number of hospital services involved in each child's care during the three month period prior to the Pediatric INTERMED interview.</description>
        <time_frame>Data collected through chart review with respect to the three month period prior to Day 1 (date of patient's participation in Pediatric Intermed interview)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Hospital Services Involved in Child's Care.</title>
          <description>Measure of number of hospital services involved in each child's care during the three month period prior to the Pediatric INTERMED interview.</description>
          <units>R Square change statistic</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.00" lower_limit="0" upper_limit="5.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>A hierarchical multiple (linear) regression analysis was conducted to determine the predictive relation between the Pediatric INTERMED indicator of case complexity and the number of hospital services involved in child's care. Gender, and time since diagnosis were entered as covariates (Step 1), followed by current disease severity (Step 2) and the Pediatric INTERMED Complexity Index (Step 3). Diagnostic tests for collinearity were conducted and all assumptions for the analysis were met.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>p&lt;0.05 Threshold for statistical significance</p_value_desc>
            <method>Regression, Linear</method>
            <param_type>Rsquare change statistic</param_type>
            <param_value>0.08</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Calls to IBD Nurse</title>
        <description>Total number of calls made by patient or parent to the IBD clinic nurse during the 3-month period prior to the Pediatric Intermed Interview</description>
        <time_frame>Data collected through chart review with respect to the three month period prior to Day 1 (date of patient's participation in Pediatric Intermed interview)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Calls to IBD Nurse</title>
          <description>Total number of calls made by patient or parent to the IBD clinic nurse during the 3-month period prior to the Pediatric Intermed Interview</description>
          <units>Number of calls</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>A hierarchical multiple (linear) regression analysis was conducted to determine the predictive relation between the Pediatric INTERMED indicator of case complexity and the number of calls to the IBD Nurse. Gender, and time since diagnosis were entered as covariates (Step 1), followed by current disease severity (Step 2) and the Pediatric INTERMED Complexity Index (Step 3). Diagnostic tests for collinearity were conducted and all assumptions for the analysis were met.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>Threshold for statistical significance is p&lt;0.01</p_value_desc>
            <method>Regression, Linear</method>
            <param_type>R2Change</param_type>
            <param_value>.05</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Extra Appointments With the IBD Team</title>
        <description>Number of extra appointments (unscheduled, emergency) with the IBD Team during the 3 month period prior to the Pediatric INTERMED interview.</description>
        <time_frame>Data collected through chart review with respect to the three month period prior to Day 1 (date of patient's participation in Pediatric Intermed interview)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Extra Appointments With the IBD Team</title>
          <description>Number of extra appointments (unscheduled, emergency) with the IBD Team during the 3 month period prior to the Pediatric INTERMED interview.</description>
          <units>Number of appointments</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>A hierarchical multiple (linear) regression analysis was conducted to determine the predictive relation between the Pediatric INTERMED indicator of case complexity and the number of extra appointments with the IBD team. Gender, and time since diagnosis were entered as covariates (Step 1), followed by current disease severity (Step 2) and the Pediatric INTERMED Complexity Index (Step 3).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>p&lt;.05 threshold for statistical significance</p_value_desc>
            <method>Regression, Linear</method>
            <method_desc>Diagnostic tests for collinearity were conducted and all assumptions for the analysis were met.</method_desc>
            <param_type>Rsquare change statistic</param_type>
            <param_value>.05</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Visits to the Hospital Emergency Department</title>
        <description>Number of times that the patient visited the hospital Emergency Department in the 3-month period prior to the Pediatric INTERMED interview.</description>
        <time_frame>Data collected through chart review with respect to the three month period prior to Day 1 (date of patient's participation in Pediatric Intermed interview)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Visits to the Hospital Emergency Department</title>
          <description>Number of times that the patient visited the hospital Emergency Department in the 3-month period prior to the Pediatric INTERMED interview.</description>
          <units>Emergency Department Visits</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>A hierarchical multiple (linear) regression analysis was conducted to determine the predictive relation between the Pediatric INTERMED indicator of case complexity and the number of ER Visits. Gender, and time since diagnosis were entered as covariates (Step 1), followed by current disease severity (Step 2) and the Pediatric INTERMED Complexity Index (Step 3). Diagnostic tests for collinearity were conducted and all assumptions for the analysis were met.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>Threshold for statistical significance is p &lt;0.05.</p_value_desc>
            <method>Regression, Linear</method>
            <param_type>R2Change</param_type>
            <param_value>.03</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Inpatient Hospital Admissions</title>
        <description>Total number of times that the patient was admitted to hospital during the 3-month period prior to the Pediatric INTERMED Interview.</description>
        <time_frame>Data collected through chart review with respect to the three month period prior to Day 1 (date of patient's participation in Pediatric Intermed interview)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Children and Youth With IBD</title>
            <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Inpatient Hospital Admissions</title>
          <description>Total number of times that the patient was admitted to hospital during the 3-month period prior to the Pediatric INTERMED Interview.</description>
          <units>Number of hospital admissions</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="3.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>A hierarchical multiple (linear) regression analysis was conducted to determine the predictive relation between the Pediatric INTERMED indicator of case complexity and the number of hospital services involved in child's care. Gender, and time since diagnosis were entered as covariates (Step 1), followed by current disease severity (Step 2) and the Pediatric INTERMED Complexity Index (Step 3). Diagnostic tests for collinearity were conducted and all assumptions for the analysis were met.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>Regression, Linear</method>
            <param_type>R2Change</param_type>
            <param_value>.07</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>At time of study participation and for 6 months following this.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Children and Youth With IBD</title>
          <description>Children/youth (ages 8-17) with confirmed diagnoses of IBD.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="148"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="148"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Janice Cohen</name_or_title>
      <organization>Children's HOspital of Eastern Ontario</organization>
      <phone>613-737-7600 ext 2497</phone>
      <email>cohen@cheo.on.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

